poisar

Stocks · News reference

J.P. Morgan Analyst Raises Kura Oncology Price Target to $32

Fiscal.ai

J.P. Morgan analyst Priyanka Grover maintained a bullish rating on Kura Oncology and increased the price target from $30 to $32.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading